CATALOGO DEI PRODOTTI DELLA RICERCA

MAGLIOZZI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.545
AS - Asia 2.228
EU - Europa 2.010
SA - Sud America 378
AF - Africa 37
OC - Oceania 12
Totale 7.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.494
SG - Singapore 855
CN - Cina 727
GB - Regno Unito 475
BR - Brasile 326
HK - Hong Kong 285
IT - Italia 285
RU - Federazione Russa 250
SE - Svezia 211
FR - Francia 185
DE - Germania 177
IE - Irlanda 174
VN - Vietnam 108
FI - Finlandia 89
KR - Corea 57
TR - Turchia 51
ID - Indonesia 39
UA - Ucraina 38
CA - Canada 36
AT - Austria 30
NL - Olanda 24
IN - India 17
BE - Belgio 15
AR - Argentina 14
BD - Bangladesh 14
JP - Giappone 13
EC - Ecuador 12
PL - Polonia 11
TG - Togo 11
AZ - Azerbaigian 10
UZ - Uzbekistan 9
CH - Svizzera 8
MX - Messico 8
AE - Emirati Arabi Uniti 7
IQ - Iraq 7
CO - Colombia 6
ES - Italia 6
NZ - Nuova Zelanda 6
ZA - Sudafrica 6
AU - Australia 5
HR - Croazia 5
LT - Lituania 5
MA - Marocco 5
PK - Pakistan 5
VE - Venezuela 5
EG - Egitto 4
PY - Paraguay 4
BG - Bulgaria 3
CL - Cile 3
DO - Repubblica Dominicana 3
IL - Israele 3
JO - Giordania 3
LA - Repubblica Popolare Democratica del Laos 3
PT - Portogallo 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
SC - Seychelles 2
TN - Tunisia 2
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 7.210
Salva come PNG Salva come JPEG
Città #
Chandler 428
Southend 424
Dallas 363
Singapore 362
Hong Kong 283
Jacksonville 185
Ashburn 181
Dublin 174
Beijing 116
Verona 114
Princeton 78
Lawrence 71
Ann Arbor 65
Jinan 61
Columbus 59
Wilmington 58
Dong Ket 56
Nanjing 53
Munich 50
Woodbridge 47
Los Angeles 44
Istanbul 42
Redmond 42
Redondo Beach 40
Jakarta 39
The Dalles 37
Houston 34
Helsinki 33
Lappeenranta 32
São Paulo 32
Tianjin 32
Buffalo 29
Shenyang 29
Changsha 27
Council Bluffs 25
Ningbo 24
Zhengzhou 24
Montréal 23
Sindelfingen 23
New York 22
Taizhou 22
Haikou 21
Nuremberg 21
Hebei 19
Redwood City 19
Santa Clara 18
Vienna 18
Hangzhou 17
Lancaster 17
Nanchang 17
Seoul 17
Seattle 15
Guangzhou 14
Ho Chi Minh City 14
Jiaxing 14
Milan 14
Rio de Janeiro 14
Brussels 13
Norwalk 13
Washington 13
Mcallen 12
Rome 12
Hanoi 11
Lomé 11
Turku 11
Baku 10
Brooklyn 10
Falls Church 10
Chicago 9
Frankfurt am Main 9
Bologna 8
Tokyo 8
Warsaw 8
Amsterdam 7
Belo Horizonte 7
Chennai 7
Dhaka 7
Falkenstein 7
London 7
Montreal 7
Padova 7
Taiyuan 7
Tashkent 7
Auckland 6
Brasília 6
Fairfield 6
Fuzhou 6
Moscow 6
Porto Alegre 6
Stockholm 6
Boardman 5
Duncan 5
San Francisco 5
Zurich 5
Atlanta 4
Boston 4
Cambridge 4
Clearwater 4
Groningen 4
Guarulhos 4
Totale 4.476
Salva come PNG Salva come JPEG
Nome #
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 202
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 160
Iron loss of thalamic nuclei evaluated with quantitative susceptibility mapping is related to intrathecal macrophages activity and cortical pathology of multiple sclerosis 128
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 127
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 125
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis 122
Epilepsy in multiple sclerosis: The role of temporal lobe damage 119
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 118
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events 116
Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats 116
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 115
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 113
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 112
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 111
Heterogeneity of cortical lesion susceptibility mapping in multiple sclerosis 111
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 107
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 105
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 104
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies 104
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 103
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 103
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 102
B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis 100
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study 99
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 98
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 97
Exploring the origins of grey matter damage in multiple sclerosis. 95
Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells 94
B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis 92
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 92
Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon 90
Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis 88
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 87
Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice 86
Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain 86
Repeated passive mobilization to stimulate vascular function in individuals of advanced age who are chronically bedridden. A randomized controlled trial 86
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 85
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables 84
Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis 83
Aging, cellular senescence, and progressive Multiple Sclerosis 81
Programmed death 1 is highly expressed on CD8+CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to EBV 80
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain 79
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 77
The vascular side of chronic bed rest: when a therapeutic approach becomes deleterious 76
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination 75
The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis 75
Can CSF biomarkers predict future MS disease activity and severity? 74
Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis 73
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology 72
Meningeal inflammation and cortical demyelination in acute multiple sclerosis 72
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration 71
Effects of the plasticiser DEHP on lung of newborn rats: catalase immunocytochemistry and morphometric analysis 71
MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course 71
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 70
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 69
Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look 69
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 69
Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein 68
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis 68
Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation 68
A gradient of neuronal loss and meningeal inflammation in multiple sclerosis 67
The BAFF / APRIL system as therapeutic target in multiple sclerosis 67
The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome 66
Lymphoid chemokines in chronic neuroinflammation 65
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study 64
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis 63
Intracerebral regulation of immune responses 62
A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis 61
Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury 55
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness 55
Intrathecal inflammation in progressive multiple sclerosis 55
Editorial: B cells in inflammatory and neurodegenerative diseases of the central nervous system 53
Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis 52
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 52
Surface-in pathology in multiple sclerosis: a new view on pathogenesis? 52
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 50
Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis 50
Chronic bedridden condition is reflected by substantial changes in plasma inflammatory profile 49
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis 48
Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation 47
Impact of neuronal loss on relaxometry and magnetization transfer imaging estimations 43
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 43
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis 43
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis 40
Differences in age-related retinal and cortical atrophy rates in multiple sclerosis 40
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination 39
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 38
snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses 35
Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics 34
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis 32
Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study 31
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 31
Comparing the pathology, clinical and demographic characteristics of younger and older-onset multiple sclerosis 30
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis 29
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II 25
Totale 7.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.625
article - articoli 31.659
book - libri 0
conference - conferenze 966
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021385 0 0 0 68 69 64 15 4 14 12 64 75
2021/2022556 36 171 1 72 18 7 19 40 20 19 30 123
2022/20231.208 86 147 115 223 68 282 22 69 157 4 18 17
2023/2024612 17 50 48 62 74 87 46 50 2 60 84 32
2024/20252.139 75 141 69 345 94 104 88 137 338 156 170 422
2025/20261.283 451 323 392 117 0 0 0 0 0 0 0 0
Totale 7.359